Fellowship · San Francisco, CA
Sponsored by University of California (San Francisco) School of Medicine
Sequencing of 53,831 diverse genomes from the NHLBI TOPMed Program.
Nature · 2021 · 1,859 citations · Shannon Kelly
Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in Children.
The New England journal of medicine · 2025 · 187 citations · Karen Rabin
Exagamglogene Autotemcel for Severe Sickle Cell Disease.
The New England journal of medicine · 2024 · 351 citations · Mark Walters
Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease.
The New England journal of medicine · 2022 · 352 citations · Mark Walters
Advancing therapy for neuroblastoma.
Nature reviews. Clinical oncology · 2022 · 353 citations · Bo Qiu
The type II RAF inhibitor tovorafenib in relapsed/refractory pediatric low-grade glioma: the phase 2 FIREFLY-1 trial.
Nature medicine · 2024 · 168 citations · Cassie Kline
The genomic landscape of pediatric acute lymphoblastic leukemia.
Nature genetics · 2022 · 338 citations ·
Adolescent and Young Adult (AYA) Oncology, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN · 2023 · 146 citations · Robert Goldsby